[Double-blind study of proglumide, zolimidine and carbenoxolone in peptic ulcer and gastroduodenitis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002229:Carbenoxolone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004378:Duodenal Diseases / Q000188:drug therapy*; D005260:Female; D005756:Gastritis / Q000188:drug therapy*; D005973:Glutamine / Q000031:analogs & derivatives*; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy*; D011377:Proglumide / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
D011725:Pyridines; D005973:Glutamine; D011377:Proglumide; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid
Studio in doppio cieco dei farmaci proglumide, zolimidina e carbenoxolone nell'ulcera peptica e nelle gastroduodeniti.